Study of an experimental drug for men with overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests an investigational drug called NNC0174-1213 to see how it works in men with overweight or mild obesity. It may help you manage your weight if you meet the health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man aged 18 to 55 years old.
- Have a BMI between 27.0 and 34.9 (overweight or mild obesity).
- Weigh at least 80 kg (about 176 lbs) at the screening visit.
- Be generally healthy based on medical history, physical exam, and lab tests.
- Not have taken certain weight loss drugs or been in another drug study recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study compares two different versions of an investigational weight-loss medication (cagrilintide) against a placebo to see which is more effective and safe for people with excess weight. Participation involves receiving injections and regular check-ins to monitor your progress.
This study tests a new injectable medication called cagrilintide for people with obesity who had to stop GLP-1 drugs (like Ozempic or Wegovy) because of stomach problems. The goal is to see if cagrilintide causes fewer stomach side effects while still helping with weight.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.